Key Financial Viability Considerations for Laboratorians Bringing Clinical Pharmacogenomics Testing into the Laboratory

Join a 56-minute webinar led by Dr. Becky Winslow, founder of inGENEious RX Inc., exploring essential financial considerations for laboratories planning to implement clinical pharmacogenomics (PGx) testing. Learn how to leverage existing laboratory equipment previously used for COVID testing for PGx applications, and discover strategies for optimizing test panel design and utilization that align with payer medical necessity definitions. Gain valuable insights into navigating coverage, reimbursement, billing, and coding guidelines for pharmacogenetic testing related to drug metabolizing enzyme gene variants, drug transporter gene variants, and genetic predispositions to adverse events and drug efficacy. Master the ability to make informed financial decisions about PGx testing implementation, understand the timeline differences between tests with existing CPT codes versus new developments, and optimize panel design for maximum laboratory profitability. Earn PACE credits valid through March 19, 2026, while learning from Dr. Winslow's extensive experience in pharmacy operations across retail, hospital, long-term care, and public health settings.